Showing 1 - 2 results of 2 for search 'J Medioni', query time: 0.01s Refine Results
  1. 1
    Safety and efficacy of combined trastuzumab-deruxtecan and concurrent radiation therapy in breast cancer. The TENDANCE multicentric French study

    Safety and efficacy of combined trastuzumab-deruxtecan and concurrent radiation therapy in breast cancer. The TENDANCE multicentric French study by K. Debbi, M.A. Benderra, J. Medioni, C. Durdux, N.H. To, C. Boukhobza, N. Grellier, A. Benmaziane, L. Monnier, J. Gligorov, E. Assaf, Y. Belkacemi

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)

    Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs) by A Daban, C Gonnin, L Phan, A Saldmann, C Granier, A Lillo-Lelouet, C Le Beller, J Pouchot, l Weiss, E Tartour, E Fabre, J Medioni, S Oudard, YA Vano, MA Dragon-Durey, A. Simonaggio

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: